Tag Archives: NASDAQ:AVEO

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AVEO Pharma (NASDAQ: AVEO), Biogen (NASDAQ: BIIB) and Immunic (NASDAQ: IMUX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AVEO Pharma (AVEO – Research Report), Biogen (BIIB – Research Report) and Immunic (IMUX – Research Report). AVEO Pharma (AVEO) In a report

H.C. Wainwright Keeps Their Buy Rating on AVEO Pharma (AVEO)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on AVEO Pharma (AVEO – Research Report), with a price target of $19.00. The company’s shares closed last Friday at $6.13, close to its 52-week low

Analysts’ Top Healthcare Picks: AVEO Pharma (AVEO), NeuBase Therapeutics (NBSE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AVEO Pharma (AVEO – Research Report), NeuBase Therapeutics (NBSE – Research Report) and Allena Pharmaceuticals (ALNA – Research Report) with bullish sentiments.

Analysts’ Top Healthcare Picks: AVEO Pharma (AVEO), Cabaletta Bio (CABA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AVEO Pharma (AVEO – Research Report), Cabaletta Bio (CABA – Research Report) and Curis (CRIS – Research Report) with bullish sentiments. AVEO

Analysts Offer Insights on Healthcare Companies: AVEO Pharma (NASDAQ: AVEO), Steris (NYSE: STE) and Harpoon Therapeutics (NASDAQ: HARP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AVEO Pharma (AVEO – Research Report), Steris (STE – Research Report) and Harpoon Therapeutics (HARP – Research Report) with bullish sentiments. AVEO

Leerink Partners Keeps Their Buy Rating on AVEO Pharma (AVEO)

Leerink Partners analyst Andrew Berens maintained a Buy rating on AVEO Pharma (AVEO – Research Report) on February 28. The company’s shares closed last Monday at $7.90. According to TipRanks.com, Berens is a 4-star analyst with an average return of